News & Updates
Filter by Specialty:

Ongoing treatment required in severe patchy hair loss
For patients with severe alopecia areata who achieved meaningful hair regrowth with 1-year course of baricitinib, subsequent discontinuation appears to reverse treatment gains, highlighting the need for ongoing therapy.
Ongoing treatment required in severe patchy hair loss
19 Aug 2024
Chemo plus atezolizumab improves survival while preserving life quality in advanced EC
Treatment with carboplatin-paclitaxel (CP) plus atezolizumab results in better quality-adjusted survival in patients with advanced or recurrent endometrial cancer (EC) as compared with CP alone, according to a post hoc analysis of the AtTEnd/ENGOT-EN7 trial.
Chemo plus atezolizumab improves survival while preserving life quality in advanced EC
19 Aug 2024
OCS use improves short-term outcomes in acute preschool wheeze
In a systematic review and individual participant data (IPD) meta-analysis, the use of oral corticosteroids (OCS) improves short-term outcomes in children aged 12–71 months with acute preschool wheeze, more so among children with previous wheeze or asthma and those with moderate-to-severe acute wheeze.
OCS use improves short-term outcomes in acute preschool wheeze
19 Aug 2024
Trans, saturated fat-heavy diets may trigger AD flares in Asians
High dietary consumption of trans fatty acids and saturated fatty acids appears to play some role in atopic dermatitis (AD) flare-ups among Chinese adults from Singapore and Malaysia, according to a large study.
Trans, saturated fat-heavy diets may trigger AD flares in Asians
18 Aug 2024
Tadalafil helps recover erectile function in young men with ED
Nearly one in two young men with primary psychogenic erectile dysfunction (ED) treated with tadalafil 5 mg once daily achieve spontaneous medication-free erectile function (EF) at 3 months, as shown in a study. Younger patients tend to have a higher chance of recovery after drug discontinuation.